NO20084190L - Anvendelse av VX-702 til behandling av revmatoid artritt - Google Patents

Anvendelse av VX-702 til behandling av revmatoid artritt

Info

Publication number
NO20084190L
NO20084190L NO20084190A NO20084190A NO20084190L NO 20084190 L NO20084190 L NO 20084190L NO 20084190 A NO20084190 A NO 20084190A NO 20084190 A NO20084190 A NO 20084190A NO 20084190 L NO20084190 L NO 20084190L
Authority
NO
Norway
Prior art keywords
treatment
rheumatoid arthritis
relates
compositions
kits
Prior art date
Application number
NO20084190A
Other languages
English (en)
Inventor
John J Alam
Robert Stephen Kauffman
Ramon Mohanlal
Christopher Godfrey
Irina Kadiyala
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of NO20084190L publication Critical patent/NO20084190L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår fremgangsmåter og sammensetninger for behandling av RA hos subjekter som trenger det. Oppfinnelsen angår også kit og farmasøytiske pakker som innbefatter sammensetninger og doseringsformer.
NO20084190A 2006-03-07 2008-10-07 Anvendelse av VX-702 til behandling av revmatoid artritt NO20084190L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77986206P 2006-03-07 2006-03-07
US78027706P 2006-03-08 2006-03-08
PCT/US2007/005882 WO2007103468A2 (en) 2006-03-07 2007-03-07 Use of vx-702 for treating rheumatoid arthritis

Publications (1)

Publication Number Publication Date
NO20084190L true NO20084190L (no) 2008-11-25

Family

ID=38475547

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084190A NO20084190L (no) 2006-03-07 2008-10-07 Anvendelse av VX-702 til behandling av revmatoid artritt

Country Status (15)

Country Link
US (1) US20070225339A1 (no)
EP (1) EP2026806A2 (no)
JP (1) JP2009529529A (no)
KR (1) KR20080100484A (no)
AR (1) AR062248A1 (no)
AU (1) AU2007223901A1 (no)
BR (1) BRPI0708645A2 (no)
CA (1) CA2644421A1 (no)
CL (1) CL2008002700A1 (no)
IL (1) IL193825A0 (no)
MX (1) MX2008011490A (no)
NO (1) NO20084190L (no)
RU (1) RU2008139625A (no)
TW (1) TW200808313A (no)
WO (1) WO2007103468A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010024226A1 (ja) * 2008-08-25 2010-03-04 参天製薬株式会社 ウレイド基、アミノカルボニル基及び置換フェニル基を置換基として有するピロール誘導体を有効成分として含有する骨・関節疾患の予防又は治療剤
WO2010038428A1 (ja) * 2008-09-30 2010-04-08 武田薬品工業株式会社 タキサン系抗がん剤の置き換え薬
US20140128633A1 (en) * 2008-12-31 2014-05-08 Raymond A. Miller Compositions containing nitro fatty acids
GB0908317D0 (en) * 2009-05-14 2009-06-24 Argenta Discovery Ltd Pharmaceutical compounds and compositions
CA2774040C (en) 2009-09-30 2014-09-09 Toray Industries, Inc. 2, 3-dihydro-1h-inden-2-yl urea derivatives and medical uses thereof
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019071147A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. INHIBITORS OF KINASE P38 REDUCING EXPRESSION OF DUX4 GENE AND DOWNSTREAM GENES FOR THE TREATMENT OF FSHD

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2515669A1 (en) * 2003-02-10 2004-08-26 Vertex Pharmaceuticals Incorporated Processes for the preparation of n-heteroaryl-n-aryl-amines by reacting an n-aryl carbamic acid ester with a halo-heteroaryl and analogous processes
US20050192261A1 (en) * 2003-09-15 2005-09-01 Jost-Price Edward R. Methods and reagents for the treatment of immunoinflammatory disorders
JP2007511521A (ja) * 2003-11-13 2007-05-10 コンビナトアールエックス インコーポレーティッド 炎症性障害を治療する方法および試薬

Also Published As

Publication number Publication date
WO2007103468A3 (en) 2008-05-29
AR062248A1 (es) 2008-10-29
KR20080100484A (ko) 2008-11-18
CA2644421A1 (en) 2007-09-13
US20070225339A1 (en) 2007-09-27
MX2008011490A (es) 2009-01-07
BRPI0708645A2 (pt) 2011-06-07
EP2026806A2 (en) 2009-02-25
WO2007103468A2 (en) 2007-09-13
CL2008002700A1 (es) 2009-05-29
AU2007223901A1 (en) 2007-09-13
IL193825A0 (en) 2009-08-03
JP2009529529A (ja) 2009-08-20
TW200808313A (en) 2008-02-16
RU2008139625A (ru) 2010-04-20

Similar Documents

Publication Publication Date Title
EA200901313A1 (ru) Ингибиторы тирозинкиназы брутона
NO20072567L (no) Triazoler nyttige som proteinkinase-inhibitorer
NO20170633A1 (no) Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff .
NO20076413L (no) Multisykliske forbindelser og fremgangsmater for deres anvendelse
NO20090157L (no) Tienpyrimidiner anvendelige som modulatorer av ionekanaler
EA200971051A1 (ru) Ингибиторы p70 s6 киназы
EA200900959A1 (ru) Ингибиторы мек
ATE530540T1 (de) Pyrimidonverbindungen als gsk-3-inhibitoren
NO20093009L (no) Kondensert ring heterocykel kinase modulatorer
NO20064852L (no) Azaindoler som er nyttige som inhibitorer av jak og andre proteinkinaser
EA200870185A1 (ru) Комбинации ингибиторов ang2 и vegf
EA201070247A1 (ru) Ингибиторы протеасом
NO20052888L (no) Diamintriazoler anvendelige som inhibitorer av proteinkinaser
EA200900091A1 (ru) Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний
EA201270553A1 (ru) Ингибиторы тирозинкиназы брутона
NO20084190L (no) Anvendelse av VX-702 til behandling av revmatoid artritt
NO20083011L (no) Modulatorer av muskarine receptorer
NO20092637L (no) Fremgangsmater for behandling
ECSP088440A (es) Imidazopirazinas como inhibidores de proteinquinasa
NO20090469L (no) Substituerte piperidiner som oker P53-aktiviteten, og anvendelse derav
NO20073628L (no) Pyridoner som er nyttige som inhibitorer av kinaser
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
EA201100062A1 (ru) Соединения и способы модулирования рецепторов, связанных с белком g
NO20091926L (no) Anti-Notch3-agonist-antistoffer og deres anvendelse ved behandlingen av Notch3-relaterte sykdommer
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application